Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How does interferon inhibit tumour growth?

I Gresser

    Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
    |September 24, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Inhibition of Plasmodium yoelii blood-stage malaria by interferon alpha through the inhibition of the production of its target cell, the reticulocyte.

    Blood·2001
    Same author

    Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

    Immunity·2001
    Same author

    William E. Stewart II.

    Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·2000
    Same author

    Regulation of type 2 nitric oxide synthase by type 1 interferons in macrophages infected with Leishmania major.

    European journal of immunology·2000
    Same author

    Three remarkable teachers.

    Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·2000
    Same author

    Murine interferon-alpha1 gene-transduced ESb tumor cells are rejected by host-mediated mechanisms despite resistance of the parental tumor to interferon-alpha/beta therapy.

    Cancer gene therapy·1999

    Interferon (IFN) can inhibit tumor growth through direct and indirect mechanisms. These effects involve slowing tumor cell multiplication and enhancing host immune responses against cancer.

    Area of Science:

    • Immunology
    • Oncology
    • Molecular Biology

    Background:

    • Interferons (IFNs) are cytokines with known roles in immune response and cell regulation.
    • Evidence suggests IFNs possess anti-tumor properties in various experimental and clinical settings.
    • The precise mechanisms by which IFNs inhibit tumor growth are complex and multifactorial.

    Purpose of the Study:

    • To elucidate the diverse mechanisms through which interferon exerts its anti-tumor effects.
    • To explore both direct impacts on tumor cells and indirect modulation of host immunity.

    Main Methods:

    • Review of experimental evidence from animal models.
    • Analysis of clinical observations in patients with benign and malignant tumors.
    • Examination of proposed molecular and cellular pathways involved in interferon's action.

    Related Experiment Videos

    Main Results:

    • Interferon can directly impede tumor cell proliferation, potentially leading to cell death.
    • IFNs may alter tumor cell surface characteristics, increasing susceptibility to host defenses.
    • Interferon can stimulate both specific and non-specific immune responses (humoral and cellular).
    • Phenotypic reversion of tumor cells has been observed following interferon treatment.

    Conclusions:

    • Interferon's anti-tumor activity is mediated by a combination of direct cytotoxic effects and immune system modulation.
    • The specific mechanisms and their relative importance are dependent on the host and tumor type.
    • Further research into interferon's therapeutic potential in oncology is warranted.